Your browser doesn't support javascript.
loading
AML with complex karyotype: extreme genomic complexity revealed by combined long-read sequencing and Hi-C technology.
Klever, Marius-Konstantin; Sträng, Eric; Hetzel, Sara; Jungnitsch, Julius; Dolnik, Anna; Schöpflin, Robert; Schrezenmeier, Jens-Florian; Schick, Felix; Blau, Olga; Westermann, Jörg; Rücker, Frank G; Xia, Zuyao; Döhner, Konstanze; Schrezenmeier, Hubert; Spielmann, Malte; Meissner, Alexander; Melo, Uirá Souto; Mundlos, Stefan; Bullinger, Lars.
Afiliación
  • Klever MK; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Sträng E; RG Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Hetzel S; Institute for Medical Genetics and Human Genetics, Charité University Medicine Berlin, Berlin, Germany.
  • Jungnitsch J; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Dolnik A; Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Schöpflin R; Institute for Medical Genetics and Human Genetics, Charité University Medicine Berlin, Berlin, Germany.
  • Schrezenmeier JF; Human Molecular Genomics Group, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Schick F; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Blau O; RG Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Westermann J; Institute for Medical Genetics and Human Genetics, Charité University Medicine Berlin, Berlin, Germany.
  • Rücker FG; Department of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Xia Z; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Döhner K; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Schrezenmeier H; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Spielmann M; Labor Berlin - Charité Vivantes GmbH, Berlin, Germany.
  • Meissner A; Division of Hematology, Oncology, and Cancer Immunology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Melo US; Labor Berlin - Charité Vivantes GmbH, Berlin, Germany.
  • Mundlos S; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
  • Bullinger L; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
Blood Adv ; 7(21): 6520-6531, 2023 11 14.
Article en En | MEDLINE | ID: mdl-37582288
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article